Adherence and persistence to drug therapies for multiple sclerosis: A population-based study-Reference-Cited by-同舟云学术

Adherence and persistence to drug therapies for multiple sclerosis: A population-based study

Published:2016-07 Issue: Volume:8 Page:78-85
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Evans Charity,Marrie Ruth Ann,Zhu Feng,Leung Stella,Lu Xinya,Melesse Dessalegn Y.,Kingwell Elaine,Zhao Yinshan,Tremlett Helen

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference43 articles.

1. Socioeconomic status and nonadherence to antihypertensive drugs: a systematic review and meta-analysis;Alsabbagh;Value Health,2014

2. BC Ministry of Health [creator], 2012. PharmaNet. V2. BC Ministry of Health [publisher]. (Data Extract. Data Stewardship Committee) (2012). 〈http://www.popdata.bc.ca/data〉.

3. Non-adherence in type 2 Diabetes: Practical Considerations for interpreting the Literature;Blackburn;Patient Preference Adherence,2013

4. Socioeconomic status and utilization of health care services in Canada and the United States - findings from a binational health survey;Blackwell;Med Care,2009

5. Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs;Borah;Curr. Med Res. Opin.,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt;Scientific Reports;2024-03-25

2. Adherence to treatment in the management of patients with multiple sclerosis;S.S. Korsakov Journal of Neurology and Psychiatry;2024

3. Predictors of treatment switching in the Big Multiple Sclerosis Data Network;Frontiers in Neurology;2023-12-22

4. Explaining the Barriers to Adherence to Treatment Regimens in Multiple Sclerosis Patients: A Qualitative Content Analysis;CRESCENT J MED BIOL;2023

5. Switching to second line MS disease-modifying therapies is associated with decreased relapse rate;Frontiers in Neurology;2023-09-06